Itau Unibanco Holding S.A.’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-380	Closed	-$2K	–	1005
2019 Q3	$2K	Hold	380	–	–	﹤0.01%	297
2019 Q2	$2K	Sell	380 -461	-55%	-$2.45K	﹤0.01%	621
2019 Q1	$3K	Hold	841	–	–	﹤0.01%	584
2018 Q4	$3K	Buy	841 +53	+7%	+$248	﹤0.01%	584
2018 Q3	$5K	Sell	788 -17	-2%	-$126	﹤0.01%	585
2018 Q2	$6K	Sell	805 -1	-0.1%	-$14	﹤0.01%	729
2018 Q1	$18K	Buy	806 +563	+232%	+$12.5K	﹤0.01%	539
2017 Q4	$3K	Buy	+243	New	+$3.57K	﹤0.01%	538

Other funds holding JNCE

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Itau Unibanco Holding S.A.'s JNCE Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q4 2019, closing a stake of 380 shares — an estimated $2K sold.

Itau Unibanco Holding S.A. first reported a position in JNCE in Q4 2017 and held it in 8 quarters. The position peaked at $18K in Q1 2018. 100 funds tracked by Wall St. Rank hold JNCE as of Q4 2019.

Itau Unibanco Holding S.A. reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 380 Jounce Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2K.
Itau Unibanco Holding S.A. first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Itau Unibanco Holding S.A.'s Jounce Therapeutics, Inc. Common Stock position peaked at $18K in Q1 2018.
100 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.